| WEEKDAY EDUCATIONAL COURSE | |||||||||||||||||||||||||||
| Clinical Applications of Ultra-High Field 7T MR - Moving to FDA/EU Approval | |||||||||||||||||||||||||||
| ORGANIZERS: Soonmee Cha, M.D. & Daniel B. Vigneron, Ph.D. | |||||||||||||||||||||||||||
| SKILL LEVEL: Intermediate | |||||||||||||||||||||||||||
| Wednesday, 11 May 2011 | |||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||
| OVERVIEW | |||||||||||||||||||||||||||
| This two-hour course will focus on the potential of ultra-high field 7T MRI to provide clinically valuable information beyond that provided by conventional 3T and 1.5T scanners. It will present the experiences and perspectives of radiologists experienced in this field, a scientist reviewing new techniques to enable additional applications and a talk outlining the requirements necessary to achieve FDA/EU approval for clinical 7T MRI exams. The talks will cover recent 7T MRI studies of patients with dementia, brain tumors, traumatic brain injury, MS, epilepsy and other diseases. Our goal is to provide the participants with an understanding of current and emerging 7T medical research applications and their potential for future clinical MRI exams. | |||||||||||||||||||||||||||
| EDUCATIONAL OBJECTIVES | |||||||||||||||||||||||||||
| Upon completion of this course participants should be able to: | |||||||||||||||||||||||||||
|
«
Describe the current state of the art in 7T medical
research; « Evaluate both the breadth and limitations of 7T MRI for the clinical characterization of human diseases; « Perform new patient MRI studies using emerging technical advances; and « Explain the requirements and challenges for obtaining FDA/EU approval for clinical 7T MRI exams. |
|||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
to view the abstract pdf and click on
